PlainRecalls
ModerateClass IIOngoing

FDA Devices recall · Reported February 14, 2024

RX Series Copper (Cu) Assay Ref. Number CU2340

Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series i…

Recall #
Z-0992-2024
Affected scope
3,053 kits (2 US, 3,051 OUS)
Initiated
November 29, 2023
Compiled from official public sources by the editorial team.
Verify with FDA Devices →
View my saved recalls

Randox Laboratories Ltd. recalled RX Series Copper (Cu) Assay Ref. Number CU2340 - a moderate-severity action.

RX Series Copper (Cu) Assay Ref. Number CU2340 was recalled by Randox Laboratories Ltd. in February 14, 2024. Reason: Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copp…. Check the official notice for the remedy. Verify recall #Z-0992-2024 with the FDA Devices before acting.

The recall

Randox Laboratories Ltd. issued this moderate-severity FDA Devices recall-Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copp….

Moderate
severity level
Class II
classification
February 14, 2024
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-0992-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Devices action (record #Z-0992-2024) was formally reported on February 14, 2024, with the manufacturer initiating the action on November 29, 2023. It is classified under Moderate severity (Class II), with a current status of Ongoing. Randox Laboratories Ltd. is listed as the recalling firm, operating out of Crumlin (North). Federal records list the affected scope as 3,053 kits (2 US, 3,051 OUS).

The documented reason for this recall is: Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper ass… Distribution data in the federal record shows the product reached: US Nationwide distribution in the states of SC and OK.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 40,322 medical devices recalls on record

-1,00001,0002,0003,0004,000 20052008201120142017202020232026 1,248
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

3,053 kits (2 US, 3,051 OUS)

Related Recalls

6

3 from same agency

Product description

RX Series Copper (Cu) Assay Ref. Number CU2340

Reason for recall

Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Ongoing
Recall number Z-0992-2024
Date reported February 14, 2024
Date initiated November 29, 2023
Recalling firm Randox Laboratories Ltd.
Firm location Crumlin (North)
Affected scope 3,053 kits (2 US, 3,051 OUS)
Distribution US Nationwide distribution in the states of SC and OK.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-0992-2024) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
RX Series Copper (Cu) Assay Ref. Number CU2340. Recalled by Randox Laboratories Ltd.. Units affected: 3,053 kits (2 US, 3,051 OUS).
Why was this product recalled?
Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 14, 2024. Severity: Moderate. Recall number: Z-0992-2024.
Where was the recalled product distributed?
Distribution: US Nationwide distribution in the states of SC and OK..
How do I check if my product is affected by a recall?
Check the product description and recall number (Z-0992-2024) against your product. Visit the official FDA Devices website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →

Browse all Medical Devices recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported February 14, 2024. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.